Digital Health: Overcoming Key Challenges
Practical strategies to overcome digital health development and deployment challenges
From improving clinical research efficiency to better understanding the patient’s experience, digital health technology is touching every aspect of pharma’s business. However, realising the benefits of digital health is not straightforward: technological challenges, regulatory obstacles, and stakeholder scepticism are just some of the concerns that need to be addressed. Where – and how – should pharma prioritise its time and investment?
Companies
Novartis, Lilly, Sanofi, Bristol Myers Squibb, Amazon, Bayer, Apple, Microsoft, Merck Group, BlueJeans, J.P. Morgan
- Subject synopsis
- Intelligence exhibits
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Decentralised clinical trials
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Telehealth/telemedicine
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- mHealth and digital therapeutics
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Medical wearable devices
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Augmented reality and virtual reality
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Differentiating digital health challenges and solutions
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Future developments in digital health
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook